What are the major opportunities in the Pelvic Inflammatory Disease (PID) Treatment market? What are the strategies for the Pelvic Inflammatory Disease (PID) Treatment market?

For detailed insights on the major opportunities and strategies in the Pelvic Inflammatory Disease (PID) Treatment market, Read More

How does the Pelvic Inflammatory Disease (PID) Treatment market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Pelvic Inflammatory Disease (PID) Treatment market growth and SWOT analysis of the Pelvic Inflammatory Disease (PID) Treatment industry, Read More

Global Pelvic Inflammatory Disease (PID) Treatment Market Report 2025

Item added to cart!

Published : December 2025

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025

Name: Pelvic Inflammatory Disease (PID) Treatment Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Treatment Type (Antibiotic Therapy, Surgery, Pain Management, Hormonal Therapy), By Route Of Administration (Oral, Intravenous, Intramuscular), By End User (Hospitals, Clinics, Homecare) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Pelvic Inflammatory Disease (PID) Treatment Market Overview

• Pelvic Inflammatory Disease (PID) Treatment market size has reached to $4.49 billion in 2024

• Expected to grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%

• Growth Driver: Increasing Sexually Transmitted Infections Drives The Growth Of The Market

• Market Trend: Lee Health Domain Introduces V-Ferin For Vaginal Health

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pelvic Inflammatory Disease (PID) Treatment Market?

Pelvic inflammatory disease (PID) treatment refers to the medical management of infections affecting the female reproductive organs, typically caused by sexually transmitted bacteria such as Chlamydia trachomatis and Neisseria gonorrhoeae. Treatment aims to eliminate the infection, alleviate symptoms, and prevent complications such as infertility, chronic pelvic pain, and ectopic pregnancy.

The main types of pelvic inflammatory disease (PID treatment are antibiotic therapy, surgery, pain management, and hormonal therapy. Antibiotic therapy is the use of antibiotics to treat bacterial infections by killing or inhibiting the growth of bacteria. It can be administered orally, intravenously, or intramuscularly, with PID treatment available in hospitals, clinics, and home care settings.

Pelvic Inflammatory Disease (PID) Treatment Market Size and growth rate 2025 to 2029: Graph

What Is The Pelvic Inflammatory Disease (PID) Treatment Market Size 2025 And Growth Rate?

The pelvic inflammatory disease (PID) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the growing adoption of telemedicine, rising incidence of sexually transmitted infections, increasing cases of sexually transmitted infections (STIs), rising awareness of pelvic inflammatory disease, and increasing healthcare expenditure.

What Is The Pelvic Inflammatory Disease (PID) Treatment Market Growth Forecast?

The pelvic inflammatory disease (PID) treatment market size is expected to see strong growth in the next few years. It will grow to $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing prevalence of sexually transmitted infections, rising awareness regarding women's reproductive health, raising awareness about pelvic inflammatory disease, increasing reliance on telehealth services, and rising incidence of sexually transmitted infections (STIs). Major trends in the forecast period include innovative pelvic inflammatory disease treatment products, advancements in diagnostic technologies, innovations such as personalized treatment, advanced imaging techniques, and technological advancements.

The forecast of 5.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. antibiotic access by increasing costs for broad-spectrum IV antibiotics and pelvic ultrasound equipment imported from India and the Netherlands, potentially delaying Pelvic Inflammatory Disease treatment and raising Obstetrics and Gynecology clinic expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Pelvic Inflammatory Disease (PID) Treatment Market Segmented?

1) By Treatment Type: Antibiotic Therapy, Surgery, Pain Management, Hormonal Therapy

2) By Route Of Administration: Oral, Intravenous, Intramuscular

3) By End User: Hospitals, Clinics, Homecare

Subsegments:

1) By Antibiotic Therapy: Broad-spectrum Antibiotics, Combination Antibiotic Therapy, Oral Antibiotics, Intravenous Antibiotics

2) By Surgery: Laparoscopy, Hysterectomy, Tubal Surgery

3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen, Localized Pain Management

4) By Hormonal Therapy: Birth Control Pills, Hormonal Intrauterine Device (IUD), Progesterone Therapy

What Is Driving The Pelvic Inflammatory Disease (PID) Treatment Market? Increasing Sexually Transmitted Infections Drives The Growth Of The Market

The increasing prevalence of sexually transmitted infections is expected to propel the growth of the pelvic inflammatory disease (PID) treatment market going forward. Sexually transmitted infections (STIs) are infections caused by bacteria, viruses, or parasites that are primarily spread through sexual contact, including vaginal, anal, or oral sex. The increasing prevalence of sexually transmitted infections (STIs) is due to factors such as risky sexual behaviors, unprotected sex, lack of awareness, delayed testing, and treatment. Pelvic inflammatory disease (PID) treatment is useful for managing sexually transmitted infections (STIs) as it involves the use of antibiotics to eliminate infection-causing bacteria, prevents complications such as chronic pelvic pain and infertility, and reduces the risk of recurrent infections. For instance, in October 2024, according to a report published by the UK Health Security Agency (UKHSA), a UK-based government agency, in 2023, England recorded 6,008 new human immunodeficiency virus (HIV) diagnoses, marking a 51% increase compared to the 3,975 diagnoses in 2022. Therefore, the increasing prevalence of sexually transmitted infections is driving the growth of the pelvic inflammatory disease (PID) treatment industry.

Who Are The Major Players In The Global Pelvic Inflammatory Disease (PID) Treatment Market?

Major companies operating in the pelvic inflammatory disease (PID) treatment market are Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.

What Are The Key Trends Of The Global Pelvic Inflammatory Disease (PID) Treatment Market? Lee Health Domain Introduces V-Ferin For Vaginal Health

Major companies operating in the pelvic inflammatory disease (PID) treatment market are focusing on innovative formulations, such as probiotic supplements, to enhance treatment efficacy, restore vaginal microbiota balance, and reduce the recurrence of infections in patients with pelvic inflammatory disease (PID). A probiotic supplement is a product containing beneficial live bacteria or yeasts that help maintain or restore a healthy balance of gut and vaginal microbiota. For instance, in November 2024, Lee Health Domain, an India-based pharmaceutical company, launched V-Ferin, a probiotic supplement designed to support vaginal health. Formulated with Lactobacillus acidophilus, lactoferrin peptide, and cranberry extract, V-Ferin aims to restore the natural microbiome and prevent common vaginal infections like bacterial vaginosis and yeast infections. With around 25-30% of women affected by these conditions, which can lead to pelvic inflammatory disease if untreated, V-Ferin offers a novel solution to improve health and prevent complications.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Pelvic Inflammatory Disease (PID) Treatment Market? Mankind Pharma Acquires Panacea Biotec To Expand Chronic And Transplant Business

In February 2022, Mankind Pharma Limited, an India-based pharmaceutical company, acquired Panacea Biotec Limited (PBL) for $212.88 million. With this acquisition, Mankind Pharma aims to strengthen its position in the chronic and transplant business by integrating its well-researched formulations and leveraging its advanced technology and niche expertise, while retaining its sales and marketing team to ensure seamless business continuity and market expansion. Panacea Biotec Limited is an India-based biotechnology company engaged in the development, manufacturing, and commercialization of pharmaceuticals, vaccines, and biosimilars for various diseases, including pelvic inflammatory disease (PID).

What Is The Regional Outlook For The Global Pelvic Inflammatory Disease (PID) Treatment Market?

North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pelvic Inflammatory Disease (PID) Treatment Market?

The pelvic inflammatory disease (PID) treatment market consists of revenues earned by entities by providing services such as medication therapy, pain management, and hospital and clinic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The pelvic inflammatory disease (PID) treatment market includes sales of antibiotics, pain relievers, and supportive care products. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pelvic Inflammatory Disease (PID) Treatment Industry?

The pelvic inflammatory disease (pid) treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pelvic inflammatory disease (pid) treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Pelvic Inflammatory Disease PID Treatment Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$4.74 billion
Revenue Forecast In 2034	$5.84 billion
Growth Rate	CAGR of 5.4% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	The pelvic inflammatory disease (PID) treatment market covered in this report is segmented – 1) By Treatment Type: Antibiotic Therapy, Surgery, Pain Management, Hormonal Therapy 2) By Route Of Administration: Oral, Intravenous, Intramuscular 3) By End User: Hospitals, Clinics, Homecare Subsegments: 1) By Antibiotic Therapy: Broad-spectrum Antibiotics, Combination Antibiotic Therapy, Oral Antibiotics, Intravenous Antibiotics 2) By Surgery: Laparoscopy, Hysterectomy, Tubal Surgery 3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs), Opioid Analgesics, Acetaminophen, Localized Pain Management 4) By Hormonal Therapy: Birth Control Pills, Hormonal Intrauterine Device (IUD), Progesterone Therapy
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc., Bayer AG, Eli Lilly and Company, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Hetero Drugs Ltd., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Dr. Reddy's Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Pharmaceuticals Inc., Torrent Pharmaceuticals Ltd., Mankind Pharma Ltd., Mayne Pharma Group Limited, Saphnix Lifesciences, Aristo Pharmaceuticals Pvt. Ltd., Zydus Cadila Healthcare Ltd., Amagen India Life Sciences.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pelvic Inflammatory Disease (PID) Treatment Market Characteristics

3. Pelvic Inflammatory Disease (PID) Treatment Market Trends And Strategies

4. Pelvic Inflammatory Disease (PID) Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Pelvic Inflammatory Disease (PID) Treatment Growth Analysis And Strategic Analysis Framework

5.1. Global Pelvic Inflammatory Disease (PID) Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pelvic Inflammatory Disease (PID) Treatment Market Growth Rate Analysis

5.4. Global Pelvic Inflammatory Disease (PID) Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pelvic Inflammatory Disease (PID) Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pelvic Inflammatory Disease (PID) Treatment Total Addressable Market (TAM)

6. Pelvic Inflammatory Disease (PID) Treatment Market Segmentation

6.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antibiotic Therapy

Surgery

Pain Management

Hormonal Therapy

6.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral

Intravenous

Intramuscular

6.3. Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Clinics

Homecare

6.4. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Broad-spectrum Antibiotics

Combination Antibiotic Therapy

Oral Antibiotics

Intravenous Antibiotics

6.5. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Laparoscopy

Hysterectomy

Tubal Surgery

6.6. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Pain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Nonsteroidal Anti-inflammatory Drugs (NSAIDs)

Opioid Analgesics

Acetaminophen

Localized Pain Management

6.7. Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Birth Control Pills

Hormonal Intrauterine Device (IUD)

Progesterone Therapy

7. Pelvic Inflammatory Disease (PID) Treatment Market Regional And Country Analysis

7.1. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market

8.1. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pelvic Inflammatory Disease (PID) Treatment Market

9.1. China Pelvic Inflammatory Disease (PID) Treatment Market Overview

9.2. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pelvic Inflammatory Disease (PID) Treatment Market

10.1. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pelvic Inflammatory Disease (PID) Treatment Market

11.1. Japan Pelvic Inflammatory Disease (PID) Treatment Market Overview

11.2. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pelvic Inflammatory Disease (PID) Treatment Market

12.1. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market

13.1. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pelvic Inflammatory Disease (PID) Treatment Market

14.1. South Korea Pelvic Inflammatory Disease (PID) Treatment Market Overview

14.2. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market

15.1. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview

15.2. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pelvic Inflammatory Disease (PID) Treatment Market

16.1. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pelvic Inflammatory Disease (PID) Treatment Market

17.1. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pelvic Inflammatory Disease (PID) Treatment Market

18.1. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pelvic Inflammatory Disease (PID) Treatment Market

19.1. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pelvic Inflammatory Disease (PID) Treatment Market

20.1. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market

21.1. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market Overview

21.2. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pelvic Inflammatory Disease (PID) Treatment Market

22.1. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pelvic Inflammatory Disease (PID) Treatment Market

23.1. North America Pelvic Inflammatory Disease (PID) Treatment Market Overview

23.2. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pelvic Inflammatory Disease (PID) Treatment Market

24.1. USA Pelvic Inflammatory Disease (PID) Treatment Market Overview

24.2. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pelvic Inflammatory Disease (PID) Treatment Market

25.1. Canada Pelvic Inflammatory Disease (PID) Treatment Market Overview

25.2. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pelvic Inflammatory Disease (PID) Treatment Market

26.1. South America Pelvic Inflammatory Disease (PID) Treatment Market Overview

26.2. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pelvic Inflammatory Disease (PID) Treatment Market

27.1. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pelvic Inflammatory Disease (PID) Treatment Market

28.1. Middle East Pelvic Inflammatory Disease (PID) Treatment Market Overview

28.2. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pelvic Inflammatory Disease (PID) Treatment Market

29.1. Africa Pelvic Inflammatory Disease (PID) Treatment Market Overview

29.2. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape And Company Profiles

30.1. Pelvic Inflammatory Disease (PID) Treatment Market Competitive Landscape

30.2. Pelvic Inflammatory Disease (PID) Treatment Market Company Profiles

30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Otsuka Pharmaceutical Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Pelvic Inflammatory Disease (PID) Treatment Market Other Major And Innovative Companies

31.1. Daiichi Sankyo Company Limited

31.2. Hetero Drugs Ltd.

31.3. Sun Pharmaceutical Industries Ltd.

31.4. Takeda Pharmaceutical Company Limited

31.5. Dr. Reddy's Laboratories Ltd.

31.6. Cipla Limited

31.7. Hikma Pharmaceuticals PLC

31.8. Lupin Pharmaceuticals Inc.

31.9. Torrent Pharmaceuticals Ltd.

31.10. Mankind Pharma Ltd.

31.11. Mayne Pharma Group Limited

31.12. Saphnix Lifesciences

31.13. Aristo Pharmaceuticals Pvt. Ltd.

31.14. Zydus Cadila Healthcare Ltd.

31.15. Amagen India Life Sciences

32. Global Pelvic Inflammatory Disease (PID) Treatment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pelvic Inflammatory Disease (PID) Treatment Market

34. Recent Developments In The Pelvic Inflammatory Disease (PID) Treatment Market

35. Pelvic Inflammatory Disease (PID) Treatment Market High Potential Countries, Segments and Strategies

35.1 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Countries Offering Most New Opportunities

35.2 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Segments Offering Most New Opportunities

35.3 Pelvic Inflammatory Disease (PID) Treatment Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Pain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Pfizer Inc. Financial Performance

Table 79: Bayer AG Financial Performance

Table 80: Eli Lilly and Company Financial Performance

Table 81: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Table 82: Astellas Pharma Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Antibiotic Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Surgery, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Pain Management, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pelvic Inflammatory Disease (PID) Treatment Market, Sub-Segmentation Of Hormonal Therapy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pelvic Inflammatory Disease (PID) Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Asia-Pacific, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: China, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: India, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Japan, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Australia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Indonesia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: South Korea, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: Western Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: UK, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: Germany, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: France, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Italy, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Spain, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Eastern Europe, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Russia, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: North America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: USA, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: Canada, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: South America, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Brazil, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Middle East, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By Route Of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Africa, Pelvic Inflammatory Disease (PID) Treatment Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Pfizer Inc. Financial Performance

Figure 79: Bayer AG Financial Performance

Figure 80: Eli Lilly and Company Financial Performance

Figure 81: Otsuka Pharmaceutical Co. Ltd. Financial Performance

Figure 82: Astellas Pharma Inc. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Rare Inflammatory Disease Treatment Global Market Report 2025 – By Drug Class (Biologics, Organic Compounds), By Mode Of Administration (Injectables, Oral, Other Administration Modes), By Indication (Ulcerative Colitis, ...

Uterine Fibroids Treatment Global Market Report 2025 – By Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids, Pedunculated Fibroids), By Treatment Type (Hormone Therapy, Androgens, Gonadotropin-Releasing...

Chlamydia Infection Treatment Global Market Report 2025 – By Treatment (Chlamydia Culture, Urine Culture, Enzyme Immunoassays, Nucleic Acid Amplification Test), By Causative Organisms (Chlamydia Trachomatis, Chlamydophil...

Urea Cycle Disorders Treatment Global Market Report 2025 – By Treatment (Amino Acid Supplements, Sodium Phenylbutyrate, Glycerol Phenylbutyrate, Sodium Benzoate, Other Treatments), By Enzyme Deficiency (Ornithine Transca...

Fibromyalgia Treatment Global Market Report 2025 – By Type (Symptomatic Treatment, Targeted Treatment), By Drug Class (Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs), By Distribution Channel ...

Polycystic Ovarian Syndrome Treatment Global Market Report 2025 – By Drug Type (Oral Contraceptives, Ornithine Decarboxylase Inhibitors, Insulin-Sensitizing Agents, Anti-Depressants, Diuretics, Aromatase Inhibitors), By ...

Crohn's Disease Treatment Global Market Report 2025 – By Drug Type (Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, O...

Frequently Asked Questions

What is the definition of the Pelvic Inflammatory Disease (PID) Treatment market?

How will the Pelvic Inflammatory Disease (PID) Treatment market drivers and restraints affect the market dynamics? What forces will shape the Pelvic Inflammatory Disease (PID) Treatment industry going forward?

The market major growth driver - Increasing Sexually Transmitted Infections Drives The Growth Of The Market. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Pelvic Inflammatory Disease (PID) Treatment market?

The pelvic inflammatory disease (pid) treatment market size has grown strongly in recent years. It will grow from $4.49 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to the growing adoption of telemedicine, rising incidence of sexually transmitted infections, increasing cases of sexually transmitted infections (STIs), rising awareness of pelvic inflammatory disease, and increasing healthcare expenditure. The pelvic inflammatory disease (pid) treatment market size is expected to see strong growth in the next few years. It will grow to " $5.84 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The growth in the forecast period can be attributed to the increasing prevalence of sexually transmitted infections, rising awareness regarding women's reproductive health, raising awareness about pelvic inflammatory disease, increasing reliance on telehealth services, and rising incidence of sexually transmitted infections (STIs). Major trends in the forecast period include innovative pelvic inflammatory disease treatment products, advancements in diagnostic technologies, innovations such as personalized treatment, advanced imaging techniques, and technological advancements. For further insights on this market, request a sample here

How is the Pelvic Inflammatory Disease (PID) Treatment market segmented?

The pelvic inflammatory disease (pid) treatmentmarket covered in this report is segmented –
1) By Treatment Type: Antibiotic Therapy; Surgery; Pain Management; Hormonal Therapy
2) By Route Of Administration: Oral; Intravenous; Intramuscular
3) By End User: Hospitals; Clinics; Homecare Subsegments:
1) By Antibiotic Therapy: Broad-spectrum Antibiotics; Combination Antibiotic Therapy; Oral Antibiotics; Intravenous Antibiotics
2) By Surgery: Laparoscopy; Hysterectomy; Tubal Surgery
3) By Pain Management: Nonsteroidal Anti-inflammatory Drugs (NSAIDs); Opioid Analgesics; Acetaminophen; Localized Pain Management
4) By Hormonal Therapy: Birth Control Pills; Hormonal Intrauterine Device (IUD); Progesterone Therapy For further insights on this market, request a sample here

Which region has the largest share of the Pelvic Inflammatory Disease (PID) Treatment market? What are the other regions covered in the report?

North America was the largest region in the pelvic inflammatory disease (PID) treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pelvic inflammatory disease (PID) treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Pelvic Inflammatory Disease (PID) Treatment market?

What are the key trends in the Pelvic Inflammatory Disease (PID) Treatment market?

Major trends in this market include Lee Health Domain Introduces V-Ferin For Vaginal Health. For further insights on this market, request a sample here.